Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

ETF What's Up

You may unsubscribe at any time by clicking the “unsubscribe” link within the emailed newsletter. By signing up, you agree to our Privacy Policy and Terms and Conditions.

HHL

Harvest Healthcare Leaders Income ETF

Active ETFEquity
Not rated

The HHL Exchange Traded Fund (ETF) is provided by Harvest Portfolios Group. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$7.53
-$0.02 (-0.26%) yesterday
1:30 PM 08/28/26 Closed
1D price range
$7.50$7.58
52W price range
$6.60$7.86
YTD Perf.
+3.90%
YTD Flows
Annualized volatility
Fund AuM
€1.3B
Share class AuM
€1.19B
TTM Yield
Tracking Error
Tracking Difference
ISIN
CA41755F1071
TER
0.98%
Inception date
12/18/2014
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Aug 27, 2026
-10%-5%0%5%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 07/31/26
Healthcare
98.89%
Unavailable
0.68%
Other
0.43%
Latest HHL news

No content available for this fund

FAQ about HHL

HHL is a Active ETF. This ETF provides exposure to Equally Weighted Large Cap Health Care Equities.
HHL carries a total expense ratio (TER) of 0.98%, indicating the annual cost for holding the fund.
HHL was introduced to the market on December 18, 2014. It trades on Canada
Harvest Healthcare Leaders Income ETF, HHL, is provided by Harvest Portfolios Group. Learn more about Harvest Portfolios Group here.
HHL oversees €1.19B in assets as of August 27, 2026.
HHL follows a distributing dividend policy, meaning it pays out income to investors. As of August 27, 2026, its 12-month trailing yield was 9.54%.
As of July 31, 2026, HHL has significant geographic allocations in USA, United Kingdom and Switzerland.
As of July 31, 2026, HHL focuses largely on Healthcare.
As of July 31, 2026, HHL holds 25 positions in its portfolio, with 74.93% of assets concentrated in its top 15 holdings.
As of July 31, 2026, HHL top three holdings include Regeneron Pharmaceuticals, Inc., Boston Scientific Corp. and Bristol Myers Squibb Co..
The base currency of HHL is CAD.
HHL is hedged, meaning it seeks to minimize the impact of currency fluctuations between its base currency and the currency of the underlying assets.
Data as of 07/31/26
Regeneron Pharmaceuticals, Inc.
5.34%
Boston Scientific Corp.
5.14%
Bristol Myers Squibb Co.
5.10%
Thermo Fisher Scientific, Inc.
5.00%
Merck & Co., Inc.
4.99%
Elevance Health, Inc.
4.99%
Amgen, Inc.
4.95%
Agilent Technologies, Inc.
4.95%
Intuitive Surgical, Inc.
4.94%
UnitedHealth Group, Inc.
4.94%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight